Dana-Farber Cancer Institute /ID# 271846

Boston, Massachusetts 02215

1 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM) — Recruiting now